Additional Proxy Soliciting Materials (definitive) (defa14a)
October 25 2022 - 04:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ |
Preliminary Proxy Statement
|
☐ |
Confidential, For Use of the Commission Only (as
permitted by 14a-6(e)(2))
|
☐ |
Definitive Proxy Statement
|
☒ |
Definitive Additional materials
|
☐ |
Soliciting Material Pursuant to §240.14a-12
|
BENITEC BIOPHARMA INC.
(Name of Registrant as Specified in Its
Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if
other than the Registrant)
Payment of filing fee (Check the appropriate box):
☐ |
Fee paid previously with preliminary materials.
|
☐ |
Fee computed on table in exhibit required by Item
25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
|

BENITEC VOTE
BIOPHARMA
silencing genes for lifeTM
Online
Go to www.investorvote.com/BNTC or scan the QR code —
login details are located in the shaded bar below.
Stockholder Meeting Notice
Important Notice Regarding the Availability of Proxy
Materials for the Benitec Biopharma Inc. Annual Stockholder Meeting
to be Held on December 7, 2022
Under Securities and Exchange Commission rules, you are
receiving this notice that the proxy materials for the annual
stockholders’ meeting are available on the Internet. Follow the
instructions below to view the materials and vote online or request
a copy. The items to be voted on and location of the annual meeting
are on the reverse side. Your vote is important!
This communication presents only an overview of the more
complete proxy materials that are available to you on the Internet.
We encourage you to access and review all of the important
information contained in the proxy materials before voting. The
proxy statement and annual report to stockholders are available
at:
www.investorvote.com/BNTC
Easy Online Access — View your proxy materials and
vote.
Step 1: Go to www.investorvote.com/BNTC.
Step 2: Click on the icon on the right to view meeting
materials.
Step 3: Return to the investorvote.com window and follow
the instructions on the screen to log in.
Step 4: Make your selections as instructed on each screen
for your delivery preferences.
Step 5: Vote your shares.
When you go online, you can also help the environment by
consenting to receive electronic delivery of future
materials.
Obtaining a Copy of the Proxy Materials – If you want to
receive a copy of the proxy materials, you must request one. There
is no charge to you for requesting a copy. Please make your request
as instructed on the reverse side on or before November 25,
2022 to facilitate timely delivery.
2NOT
03PDOC

Stockholder Meeting Notice
Benitec Biopharma Inc.’s Annual Meeting of Stockholders
will be held on December 7, 2022 at
https://meetnow.global/MVNT77G at 3:00 p.m. Pacific
Time.
Proposals to be voted on at the meeting are listed below
along with the Board of Directors’ recommendations.
The Board of Directors recommend a vote FOR all the
nominees listed and FOR Proposals 2-7:
1. Election of Directors:
01—Dr. Jerel Banks
02—Megan Boston
2. Ratification of the appointment of the Company’s
independent registered public accounting firm for the fiscal year
ending June 30, 2023.
3. Approval, as a non-binding advisory vote, of the
compensation of the Company’s named executive officers as disclosed
in the attached proxy statement.
4. Approval of an amendment to the Company’s Amended and
Restated Certificate of Incorporation to increase the number of
authorized shares of common stock from 40,000,000 shares to
160,000,000 shares.
5. Approval of an amendment to the Company’s Amended and
Restated Certificate of Incorporation to authorize 5,000,000 shares
of preferred stock, par value $0.0001 per share.
6. Approval of an amendment to the Company’s Amended and
Restated Certificate of Incorporation to effect a reverse stock
split of the Company’s common stock at a ratio in the range of
1-for-5 to 1-for-20, such ratio to be
determined in the discretion of the Company’s Board of
Directors.
7. Approval of an adjournment of the Annual Meeting, if
necessary, to solicit additional proxies if there are not
sufficient votes in favor of the other proposals in this Proxy
Statement.
PLEASE NOTE – YOU CANNOT VOTE BY RETURNING THIS NOTICE.
To vote your shares you must go online or request a paper copy of
the proxy materials to receive a proxy card.
Here’s how to order a copy of the proxy materials and
select delivery preferences:
Current and future delivery requests can be submitted
using the options below.
If you request an email copy, you will receive an email
with a link to the current meeting materials.
PLEASE NOTE: You must use the number in the shaded bar on
the reverse side when requesting a copy of the proxy
materials.
— Internet – Go to www.investorvote.com/BNTC.
— Phone – Call us free of charge at 1-866-641-4276.
— Email – Send an email to investorvote@computershare.com
with “Proxy Materials Benitec” in the subject line. Include your
full name and address, plus the number located in the shaded bar on
the reverse side, and state that you want a paper copy of the
meeting materials.
To facilitate timely delivery, requests for a paper copy
of proxy materials must be received by November 25,
2022.
Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Jan 2023 to Feb 2023
Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Feb 2022 to Feb 2023